NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.
企業コードNAOV
会社名Nanovibronix Inc
上場日Apr 24, 2015
最高経営責任者「CEO」Dr. Doron Besser, M.D.
従業員数15
証券種類Ordinary Share
決算期末Apr 24
本社所在地969 Pruitt Piace
都市TYLER
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号75703
電話番号19142333004
ウェブサイトhttps://nanovibronix.com/
企業コードNAOV
上場日Apr 24, 2015
最高経営責任者「CEO」Dr. Doron Besser, M.D.
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし